All terms in EFO
| Label | Id | Description |
|---|---|---|
| disorder of phospholipids, sphingolipids and fatty acids biosynthesis | MONDO_0018117 | |
| mitochondrial DNA depletion syndrome | MONDO_0018158 | [The mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterized by a reduction of the mtDNA copy number in affected tissues without mutations or rearrangements in the mtDNA. MDS is phenotypically heterogeneous, and can affect a specific organ or a combination of organs, with the main presentations described being either hepatocerebral (i.e. hepatic dysfunction, psychomotor delay), myopathic (i.e. hypotonia, muscle weakness, bulbar weakness), encephalomyopathic (i.e. hypotonia, muscle weakness, psychomotor delay) or neurogastrointestinal (i.e gastrointestinal dysmotility, peripheral neuropathy). Additional phenotypes include fatal infantile lactic acidosis with methylmalonic aciduria, spastic ataxia (early-onset spastic ataxia-neuropathy syndrome), and Alpers syndrome.] |
| progesterone measurement | EFO_0007004 | [quantification of progesterone in a sample] |
| progesterone | CHEBI_17026 | [A 3-oxo Delta(4)-steroid that has formula C21H30O2., A steroid hormone that has formula C21H30O2.] |
| disease of genitourinary system | EFO_0009663 | [A disease that involves the genitourinary system. [database_cross_reference: MONDO:patterns/location]] |
| carnosinemia | MONDO_0008921 | [Carnosinemia is a very rare inherited disorder that presents with serum carnosinase deficiency.] |
| homocarnosinosis | MONDO_0009351 | [Homocarnosinosis is a metabolic defect characterised by progressive spastic diplegia, intellectual deficit and retinitis pigmentosa. This extremely rare disorder has been reported in only one family, namely a woman and three of her children. The latter showed progressive spastic diplegia, mental retardation and retinitis pigmentosa but their mother was symptom free. It is therefore uncertain whether there is a relationship between the biochemical defect and the clinical symptoms. Inheritance in the reported family seems to be autosomal dominant.] |
| disease of orbital region | EFO_0009664 | [A disease that involves the orbital region., A disease that involves the orbital region. [database_cross_reference: MONDO:patterns/location]] |
| face disorder | MONDO_0044987 | [A disease or disorder that involves the face.] |
| prolactin measurement | EFO_0007003 | [quantification of prolactin in a sample] |
| skin pigmentation measurement | EFO_0007009 | [quantification of some aspect of skin pigmentation, such as saturation, darkness or skin sensitivity to sun] |
| skin pigmentation | EFO_0003784 | [Coloration of the skin.] |
| allergy measurement | EFO_0007008 | [quantification of some aspect of an allergy, for example whether an allergy is present or its severity. Allergies are commonly quantified through measurement of allergen-specific IgE in the blood or skin reaction after puncture of skin through a droplet of allergen extract (skin prick test)] |
| allergic disease | MONDO_0005271 | [An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.] |
| 3-(1H-indol-3-yl)propanoic acid | CHEBI_43580 | [An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.] |
| ticagrelor measurement | EFO_0007007 | [Quantification of the amount of ticagrelor in a sample. Ticagrelor is a platelet aggregation inhibitor used for the prevention of thrombotic events in people with acute coronary syndrome or myocardial infarction with ST elevation.] |
| flatulence | EFO_0009669 | [A state of excessive gas in the alimentary canal. [ NCI ]] |
| obsolete_syndromic hair shaft abnormality | Orphanet_79367 | |
| obsolete_alopecia | Orphanet_79364 | |
| external yolk syncytial layer | UBERON_2000309 | [The portion of the YSL that is outside of the blastoderm margin during epiboly. Kimmel et al, 1995.] |